tiprankstipranks
Vaxcyte, Inc. Navigates AI Risks Amidst Regulatory and Ethical Challenges
PremiumCompany AnnouncementsVaxcyte, Inc. Navigates AI Risks Amidst Regulatory and Ethical Challenges
1M ago
Vaxcyte Reports Progress and Strengthens Financial Position
Premium
Company Announcements
Vaxcyte Reports Progress and Strengthens Financial Position
2M ago
Vaxcyte reports Q3 EPS (83c), consensus ($1.13)
Premium
The Fly
Vaxcyte reports Q3 EPS (83c), consensus ($1.13)
2M ago
Vaxcyte price target raised to $130 from $101 at Guggenheim
PremiumThe FlyVaxcyte price target raised to $130 from $101 at Guggenheim
4M ago
Vaxcyte price target raised to $140 from $101 at BofA
Premium
The Fly
Vaxcyte price target raised to $140 from $101 at BofA
4M ago
Vaxcyte announces $1B common stock and warrants offering
Premium
The Fly
Vaxcyte announces $1B common stock and warrants offering
4M ago
Vaxcyte price target raised to $160 from $98 at BTIG
PremiumThe FlyVaxcyte price target raised to $160 from $98 at BTIG
4M ago
Morning Movers: U.S. Steel drops after VP Harris opposes sale to Nippon
Premium
The Fly
Morning Movers: U.S. Steel drops after VP Harris opposes sale to Nippon
4M ago
Vaxcyte’s VAX-31 Shows Promise in Pneumococcal Disease Trial
Premium
Company Announcements
Vaxcyte’s VAX-31 Shows Promise in Pneumococcal Disease Trial
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100